October 27, 2020

Volume X, Number 301

Advertisement

October 27, 2020

Subscribe to Latest Legal News and Analysis

October 26, 2020

Subscribe to Latest Legal News and Analysis
Advertisement

Focus on Life Sciences After the Curve [PODCAST]

In this time of crisis, the life science industry has demonstrated remarkable speed, innovation and resilience. In this episode of the After the Curve podcast, our life sciences partners join us to discuss the most promising areas of drug discovery and device development that are emerging from the pandemic and the outlook for the industry in a post-COVID-19 world. McDermott’s Chief Marketing Officer, Leslie Tullio, is joined by Stephen Bernstein and Kristian Werling to discuss key topics impacting the life sciences industry today, including:

  • The reasons behind the immunity of life sciences to slowed investments

  • Why more investors are focusing their equity in healthcare and life sciences

  • Promising areas of drug discovery and device development emerging from the pandemic

  • Critical considerations for life science companies regarding rapid regulatory changes

  • Tactics for moving developments forward at an increased speed

  • The importance of Collaborative Transformation to the life sciences industry

© 2020 McDermott Will & EmeryNational Law Review, Volume X, Number 275
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement
Advertisement

About this Author

McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,100 lawyers, we have offices in Boston, Brussels, Chicago, Düsseldorf, Frankfurt, Houston,...

+1 312 372 2000
Advertisement
Advertisement